Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Liminal BioSciences Inc. PFSCF


Primary Symbol: LMNL

Liminal BioSciences is a biopharmaceutical company focused on the discovery and development of novel, small molecule drug candidates for the treatment of patients suffering from fibrotic or inflammatory diseases that have a high unmet medical need. Liminal BioSciences operates on an integrated basis from our talent hubs in Laval, Quebec, Canada, and Cambridge, UK. Our common shares are listed for trading on the Nasdaq Global Market.


NDAQ:LMNL - Post by User

Comment by GunnerGon Jun 11, 2021 8:55pm
67 Views
Post# 33376982

RE:RE:RE:look what i found:) __ article lmnl__

RE:RE:RE:look what i found:) __ article lmnl__The simple answer would be to read the NR, however lacking in legalize.  LOL

Here is the SEC filing which you can go through look for voucher (2) and PRV (19).

Share Purchase Agreement

I did find this, it looks like PBT will be selling the PRV not Kedrion.

(ii)

upon the sale of the PRV (if granted) by PBT and completion of the transactions described in Section 4(a)(ii)(2) before Closing (1) a non-refundable cash payment of [***] for the PBT Shares; and (2) [***]; and (ii) [***]. The Parties will reasonably cooperate to define the invoicing and payment conditions of the Milestone Payment in the Definitive Agreement. [***].


I didn't have time to read the entire doc.  Have fun, it's a little longer than the NR.



stockman6767 wrote: Is there any requirement that Kedrion sell the PVR voucher? What if they want to use it for their own future fees at the FDA in their own trials. Then there would be zero cash coming from the voucher for LMNL. Anyone aware what the language is in the sale to Kedrion and whether they have to sell the PVR?


<< Previous
Bullboard Posts
Next >>